Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers. These nanomedical innovations may form the core elements of advanced extravehicular space suits that have numerous advantages, such as continuous real-time health monitoring, virtually instantaneous in situ diagnostics, the auto-administration of therapeutics, and the capacities to address serious accidental circumstances and performance of emergency interventions.
Coronavirus hits the old and those with other health problems hardest, but fit, youthful people are dying too, and experts are trying to understand why: It remains one of [...]
he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood [...]
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness [...]
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of [...]
How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles [...]
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, [...]
About NanoApps Medical Inc
NanoApps Medical, Inc. was incorporated by Frank Boehm in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.
The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.
Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.